AMRX - Amneal Pharmaceuticals misses by $0.04 beats on revenue May, 09 2019 06:34 AM Amneal Pharmaceuticals Inc. Class A Amneal Pharmaceuticals (NYSE:AMRX): Q1 Non-GAAP EPS of $0.14 misses by $0.04; GAAP EPS of -$0.37.More news on: Amneal Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...